149 related articles for article (PubMed ID: 36418169)
1. A Multicenter Study on Observed Discrepancies Between Vendor-Stated and PET-Measured
Gnesin S; Mikell JK; Conti M; Prior JO; Carlier T; Lima TVM; Dewaraja YK
J Nucl Med; 2023 May; 64(5):825-828. PubMed ID: 36418169
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo Simulations Corroborate PET-Measured Discrepancies in Activity Assessments of Commercial
Auditore L; Pistone D; Italiano A; Amato E; Gnesin S
J Nucl Med; 2023 Sep; 64(9):1471-1477. PubMed ID: 37442605
[TBL] [Abstract][Full Text] [Related]
3. Predicting the net administered activity in
Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC
Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198
[TBL] [Abstract][Full Text] [Related]
4.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
5. High quality imaging and dosimetry for yttrium-90 (
Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
[TBL] [Abstract][Full Text] [Related]
6. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
7. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization with
Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
[TBL] [Abstract][Full Text] [Related]
9. Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres.
Ebbers SC; Kunnen B; van Nierop BJ; Bemelmans JLM; Krijger GC; Lam MGEH; Braat AJAT
Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1378-1383. PubMed ID: 32435831
[TBL] [Abstract][Full Text] [Related]
10. Technical Note: Impact of impurities on Yttrium-90 glass microsphere activity quantitation.
Beattie BJ; Kirov AS; Kesner AL
Med Phys; 2024 Mar; 51(3):2306-2310. PubMed ID: 37956259
[TBL] [Abstract][Full Text] [Related]
11. Resin Versus Glass Microspheres for
Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
[TBL] [Abstract][Full Text] [Related]
12. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
[TBL] [Abstract][Full Text] [Related]
13. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
[TBL] [Abstract][Full Text] [Related]
14. PET-CT post therapy dosimetry in radioembolization with resin
Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
[TBL] [Abstract][Full Text] [Related]
15. Comparative dosimetry between
Jadoul A; Bernard C; Lovinfosse P; Gérard L; Lilet H; Cornet O; Hustinx R
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):828-837. PubMed ID: 31388721
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
Garin E; Rolland Y; Laffont S; Edeline J
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
[TBL] [Abstract][Full Text] [Related]
17. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
18. A gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver.
Kao YH; Luddington OS; Culleton SR; Francis RJ; Boucek JA
J Nucl Med Technol; 2014 Dec; 42(4):265-8. PubMed ID: 25472514
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
